1. Department of Internal Medicine III, University of Ulm, Ulm, Germany;
2. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
3. Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom;
4. Department of Biomedicine and Prevention, Università di Roma “Tor Vergata,” Rome, Italy;
5. Department of Hematology/Oncology, University of Münster, Münster, Germany;
6. Institut Universitaire d’Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France;
7. Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
8. Service d’Hématologie, Hôpital Saint-Louis, Paris, France;
9. Department of Medicine, University of Chicago, Chicago, IL;
10. Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
11. National Hospital Organization Nagoya Medical Center, Nagoya, Japan;
12. Department of Hematology, Oncology and Hemostasis, University of Leipzig, Leipzig, Germany;
13. Department of Haematology, Vrije Universiteit University Medical Center, Amsterdam, The Netherlands;
14. Department of Hematology, University Hospital La Fe, University of Valencia, Valencia, Spain;
15. Hematology Department, Hospital de la Santa Creu i Sant Pau, Jose Carreras Leukemia Research Institute, Barcelona, Spain;
16. Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan;
17. Department of Clinical Hematology, The Alfred Hospital, Melbourne, Australia;
18. Australian Centre for Blood Diseases, Monash University, Melbourne, Australia;
19. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands; and
20. The Ohio State University Comprehensive Cancer Center, Columbus, OH